Membranous glomerulonephritis is a manifestation of IgG4-related disease

Kidney International

Volumn 83, Issue 3, 2013, Pages 455-462

  Alexander, Mariam P ^a   Larsen, Christopher P ^b   Gibson, Ian W ^c   Nasr, Samih H ^a   Sethi, Sanjeev ^a   Fidler, Mary E ^a   Raissian, Yassaman ^a   Takahashi, Naoki ^a   Chari, Suresh ^a   Smyrk, Thomas C ^a   Cornell, Lynn D ^a  

^a MAYO CLINIC   (United States)

^b Nephropathology Associates   (United States)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

autoimmune pancreatitis; IgG4 related sclerosing disease; interstitial nephritis; membranous glomerulopathy; membranous nephropathy

Indexed keywords

CREATININE; IMMUNOGLOBULIN G4; IMMUNOSUPPRESSIVE AGENT; PHOSPHOLIPASE A2 RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN G4 RELATED DISEASE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; MEDICAL HISTORY; MEMBRANOUS GLOMERULONEPHRITIS; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; RENOGRAPHY; SEROLOGY; TREATMENT RESPONSE;

EID: 84874584542     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.382     Document Type: Article

References (37)

1. Sarles H, Sarles JC, Muratore R et al. Chronic inflammatory sclerosis of the pancreas-an autonomous pancreatic disease? Am J Dig Dis 1961; 6: 688-698
2. Cheuk W, Chan JK. IgG4-related sclerosing disease: A critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol 2010; 17: 303-332
3. Shrestha B, Sekiguchi H, Colby TV et al. Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis: Report of 6 and 12 cases with similar histopathology. Am J Surg Pathol 2009; 33: 1450-1462
4. Deshpande V, Chicano S, Finkelberg D et al. Autoimmune pancreatitis: A systemic immune complex mediated disease. Am J Surg Pathol 2006; 30: 1537-1545
5. Zen Y, Kasahara Y, Horita K et al. Inflammatory pseudotumor of the breast in a patient with a high serum IgG4 level: Histologic similarity to sclerosing pancreatitis. Am J Surg Pathol 2005; 29: 275-278
6. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012; 366: 539-551
7. Cornell LD, Chicano SL, Deshpande V et al. Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol 2007; 31: 1586-1597
8. Raissian Y, Nasr SH, Larsen CP et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol 2011
9. Saeki T, Imai N, Ito T et al. Membranous nephropathy associated with IgG4-related systemic disease and without autoimmune pancreatitis. Clin Nephrol 2009; 71: 173-178
10. Kawano M, Saeki T, Nakashima H et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol 2011; 15: 615-26
11. Saeki T, Nishi S, Imai N et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int 2010; 78: 1016-1023
12. Morimoto J, Hasegawa Y, Fukushima H et al. Membranoproliferative glomerulonephritis-like glomerular disease and concurrent tubulointerstitial nephritis complicating IgG4-related autoimmune pancreatitis. Intern Med 2009; 48: 157-162
13. Saida Y, Homma N, Hama H et al. Case of IgG4-related tubulointerstitial nephritis showing the progression of renal dysfunction after a cure for autoimmune pancreatitis. Nihon Jinzo Gakkai Shi 2010; 52: 73-79
14. Jindal N, Yadav D, Passero C et al. Membranous nephropathy: A rare renal manifestation of IgG4-related systemic disease. Clin Nephrol 2012; 77: 321-328
15. Katano K, Hayatsu Y, Matsuda T et al. Endocapillary proliferative glomerulonephritis with crescent formation and concurrent tubulointerstitial nephritis complicating retroperitoneal fibrosis with a high serum level of IgG4. Clin Nephrol 2007; 68: 308-314
16. Naitoh I, Nakazawa T, Ohara H et al. Autoimmune pancreatitis associated with various extrapancreatic lesions during a long-term clinical course successfully treated with azathioprine and corticosteroid maintenance therapy. Intern Med 2009; 48: 2003-2007
17. Cravedi P, Abbate M, Gagliardini E et al. Membranous nephropathy associated with IgG4-related disease. Am J Kidney Dis 2011; 58: 272-275
18. Uchiyama-Tanaka Y, Mori Y, Kimura T et al. Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis. Am J Kidney Dis 2004; 43: E18-25
19. Yamaguchi Y, Kanetsuna Y, Honda K et al. Characteristic tubulointerstitial nephritis in IgG4-related disease. Hum Pathol 2011; 43: 536-49
20. Fervenza FC, Downer G, Beck LH Jr et al. IgG4-related tubulointerstitial nephritis with membranous nephropathy. Am J Kidney Dis 2011; 58: 320-324
21. Watson SJ, Jenkins DA, Bellamy CO. Nephropathy in IgG4-related systemic disease. Am J Surg Pathol 2006; 30: 1472-1477
22. Beck LH Jr, Bonegio RG, Lambeau G et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361: 11-21
23. Stone JH, Khosroshahi A, Deshpande V et al. IgG4-related disease: Recommendations for the nomenclature of this condition and its individual organ system manifestations. Arthritis Rheum 2012; 64: 3061-7
24. Imai H, Hamai K, Komatsuda A et al. IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. Kidney Int 1997; 51: 270-276
25. Debiec H, Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med 2011; 364: 689-690
26. Khosroshahi A, Ayalon R, Beck LH Jr et al. IgG4-related disease is not associated with antibody to the phospholipase A2 receptor. Int J Rheumatol 2012; 2012: 139409
27. Geyer JT, Deshpande V. IgG4-associated sialadenitis. Curr Opin Rheumatol 2011; 23: 95-101
28. Khosroshahi A, Bloch DB, Deshpande V et al. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 2010; 62: 1755-1762
29. Khosroshahi A, Carruthers MN, Deshpande V et al. Rituximab for the treatment of IgG4-related disease: Lessons from 10 consecutive patients. Medicine 2012; 91: 57-66
30. Moseley HL, Whaley K. Control of complement activation in membranous and membranoproliferative glomerulonephritis. Kidney Int 1980; 17: 535-544
31. Rodriguez EF, Cosio FG, Nasr SH et al. The pathology and clinical features of early recurrent membranous glomerulonephritis. Am J Transplant 2012; 12: 1029-1038
32. Lhotta K, Wurzner R, Konig P. Glomerular deposition of mannose-binding lectin in human glomerulonephritis. Nephrol Dial Transplant 1999; 14: 881-886
33. Segawa Y, Hisano S, Matsushita M et al. IgG subclasses and complement pathway in segmental and global membranous nephropathy. Pediatr Nephrol 2010; 25: 1091-1099
34. Ma H, Beck LH Jr, Salant DJ. (eds) Membranous nephropathy-associated anti-phospholipase A2 receptor IgG4 autoantibodies activate the lectin complement pathway. American Society of Nephrology Annual Meeting, Philadelphia, PA, November 11, 2011
35. Rispens T, Ooievaar-De Heer P, Vermeulen E et al. Human IgG4 binds to IgG4 and conformationally altered IgG1 via Fc-Fc interactions. J Immunol 2009; 182: 4275-4281
36. Deshpande V, Zen Y, Chan JK et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012; 25: 1181-92
37. Debiec H, Lefeu F, Kemper MJ et al. Early-childhood membranous nephropathy due to cationic bovine serum albumin. N Engl J Med 2011; 364: 2101-2110